NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Heart Disease Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Heart Disease Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Heart Disease



University of Tubingen reports research in heart disease



July 6th, 2008

In this recent report published in the journal Heart, researchers in Tubingen, Germany conducted a study "To evaluate residual platelet activity in a consecutive cohort of patients treated with dual antiplatelet therapy after coronary stent implantation Design: Prospective single-centre cohort study. University hospital in Germany."

"480 patients with symptomatic coronary artery disease (n = 221 (46%) or acute coronary syndrome (ACS; n = 259 (54%) stable angina) were studied. Platelet activity was measured by collagen- (5 mg/ml) and adenosine diphosphate- (ADP; 20 mu mol/l) induced platelet aggregation to assess post-treatment activity in patients treated with...


Source: Heart Disease Weekly (2008-07-06)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login